Baxter: Tests show suspect heparin was pure

Baxter International has determined that quality issues weren't involved in the deaths of two patients who took the company's heparin products. An array of forensic and analytical tests verify the heparin products were pure and didn't contain any contaminants, Baxter said. Report

Suggested Articles

Pfizer's diagnosis-focused launch strategy for Vyndaqel and Vyndamax is paying off with the meds reaching thousands of patients already.

Pfizer terminated a slew of trial cohorts testing Bavencio in combination with its own experimental drugs, as well as one monotherapy trial.

With its Eli Lilly-partnered Olumiant nearing filing in atopic dermatitis, Incyte's other JAK med Jakafi is also looking for a win in that indication.